Responses of pigs to a re-challenge with Actinobacillus pleuropneumoniae after being treated with different antimicrobials following their initial exposure
- M. Sjölund, DVM1,
- A. J. Martín de la Fuente, DVM, PhD2,
- C. Fossum, PhD3 and
- P. Wallgren, DVM, PhD, DipECPHM1
- 1 National Veterinary Institute, Department of Animal Health and Antimicrobial Strategies, SE-751 89 Uppsala, Sweden
- 2 Departamento de Sanidad Animal, Unidad de Microbiología e Immunología, Facultad de Veterinaria, Universidad de León, 24007, León, Spain
- 3 Swedish University of Agricultural Sciences, Department of Biomedicine and Veterinary Public Health, Section of Immunology, PO Box 588, Biomedical Centre, SE-751 23 Uppsala, Sweden
Four groups of six specific pathogen-free (SPF) pigs were inoculated intranasally with Actinobacillus pleuropneumoniae serotype 2 and treated with either enrofloxacin, tetracycline or penicillin at the onset of clinical disease, or left untreated. A fifth group was left uninoculated. The inoculated control and the penicillin-treated groups developed severe disease, but the groups treated with enrofloxacin and tetracycline recovered rapidly. All the inoculated pigs, except those treated with enrofloxacin developed serum antibodies to A pleuropneumoniae. On day 28, all five groups were challenged with A pleuropneumoniae without any subsequent treatment. The previously uninoculated control group and the enrofloxacin-treated group developed severe disease, but the three seropositive groups remained unaffected.
- British Veterinary Association. All rights reserved.